ravi-venkata-durvasula
Ravi Venkata Durvasula
Professor

Department of Medicine and Infectious Diseases
University of New Mexico School of Medicine
USA

Education

  • McGill University, Montreal, Quebec, Canada M.D., C.M., 1989
  • McGill University, Montreal, Quebec, Canada B. Sc. in Biology, 1985 with great distinction

 

Biography

 

Research Interest

Professional Activities:

Postgraduate Training/ Work Experience

2011- present University of New Mexico School of Medicine, Albuquerque, NM
Professor of Medicine and Infectious Diseases; Tenured in 2009
2010-present New Mexico VA Health Care System, Albuquerque, NM
Acting Associate Chief of Staff for Research
2005-present New Mexico VA Health Care System, Albuquerque, NM
Chief of Medicine, Albuquerque VA Medical Center; Vice Chairman of Department of Internal Medicine, UNM School of Medicine
2005-2010 University of New Mexico School of Medicine, Albuquerque, NM
Associate Professor of Internal Medicine and Infectious Diseases; granted tenure in 2009
2005-present University of New Mexico School of Medicine, Albuquerque, NM
Director, Program in Global and Geographic Medicine (’05-10)
Director, Center for Global Health (2010-present)
2001- 05 Yale University Health Services, New Haven, CT
Medical Director
Yale University School of Medicine, New Haven, CT
Assistant Clinical Professor, Dept. of Epidemiology and Public Health
2000‑ 01 Yale University Health Services, New Haven, CT
Chief of Clinical Resources
Chief, Dept. of Laboratory Medicine
2000‑ 01 Yale University School of Medicine, New Haven, CT
Associate Research Scientist and Lecturer, Dept. of Epidemiology and Public Health
1997‑1999 Yale University School of Medicine, New Haven, CT
Instructor, Dept. of Internal Medicine
1994‑1997 Howard Hughes Medical Institute/ Yale University School of Medicine
Howard Hughes Physician Postdoctoral Fellow
1993‑1996 Yale University School of Medicine, New Haven, CT
Fellow, Section of Infectious Diseases
1992‑1993 Yale University School of Medicine, New Haven, CT
Postgraduate Research Associate, Section of Infectious Diseases
1992 Baylor College of Medicine/ Methodist Hospital, Houston, TX
Chief Medical Resident
1989‑1992 Baylor College of Medicine, Houston, TX
Resident, Department of Internal Medicine

Current Professional Activities: National and International

  • Editorial Board Member, Frontiers in Immunology(Review Editor)
  • Councilor, Western Association of Physicians (2012-2015)
  • President-Elect, Western Association of Physicians (2014)
  • Reviewer, American Journal of Tropical Medicine and Hygiene
  • Reviewer, Emerging Infectious Diseases
  • Reviewer, Insect Molecular Biology and Biochemistry
  • Reviewer, Symbiosis
  • Reviewer, American Journal of Public Health
  • Reviewer, Journal of Applied Microbiology
  • Reviewer, Parasites and Vectors
  • Reviewer, Letters in Applied Microbiology
  • Reviewer, PLoS One
  • Reviewer, PLoS Neglected Tropical Diseases
  • Member, American Society of Tropical Medicine and Hygiene
  • Member, Burroughs Wellcome Trust Fund Fellowship Committee, American Society of Tropical Medicine and Hygiene
  • Ad hoc Reviewer for BARD, the United States - Israel Binational Agricultural Research &Development Fund
  • Ad hoc Reviewer for NSERC (Canada)
  • Member, Steering Committee, Pew Initiative on Food and Biotechnology  Genetically Modified Insects Conference (’04)
  • Member, IRSDA Study Section: NIH-NIAID (ad hoc 2005)
  • Member, Global Infectious Diseases Study Section: NIH-CSR (ad hoc 2006)
  • Member, Tropical Medicine Research Center Study Section: NIH-NIAID (ad hoc 2006)
  • Member, International Research in Infectious Diseases Study Section: NIH-NIAID ( 2007, 2008, 2009)
  • Member, Global Infectious Diseases Study Section: NIH-NIAID ( 2008,2009)
  • Member, Translational Research in Vector Borne Diseases Study Section: NIH-NIAID 2009

Appointed Chartered Member of ICP-1 Study Section: NIH-NIAID 2009

  • Member, ICIDR Study Section: NIH-NIAID (ad hoc 2009)
  • Member, Tropical Medicine Research Center Study Section: NIH-NIAID (ad hoc 2011)
  • Member, Clinical Trials and Planning Study Section (UO1 and R25): NIH-NIAID (ad hoc 2012)
  • Member, Vectors and Parasites Study Section: NIH-NIAID (ad hoc 2012)
  • Member, PRMPR Leishmaniasis Study Section, Dept. of Defense 2013
  • Member, Pathogens and Vectors Study Section: NIH-NIAID (ad hoc 2014)

Chair, Global Infectious Diseases Study Section: NIH- Fogarty (2014)

Professional Activities and Memberships: Yale University 2001-2005

  • Member, Board of University Health, Yale University
  • Chair, Measures and Technology Committee, Yale Univ. Health Services
  • Member, Quality Management Committee, Yale Univ. Health Services
  • Member, Pharmacy and Therapeutics Committee, Yale Univ. Health Service
  • Member, Research and Education Committee, Yale Univ. Health Services
  • Member, Medical Information and Records Committee, Yale Univ. Health Services
  • Chair, Office of Population Medicine, Yale University Health Services
  • Chair, Medical Review Committee, Yale University Health Services
  • Member, Committee on International Health, Yale University School of Medicine
  • Member, South Asian Studies Council, Yale University

Professional Activities and Memberships: New Mexico VA Health Care System And University of New Mexico: 2005-

  • Acting Chief of Staff, New Mexico VA Health Care System, Dec. 2005-March 2006
  • Co-Chair, Performance Improvement Committee, Albuquerque VA Medical Center
  • Member, Medical Executive Committee, Albuquerque VA Medical Center
  • Member, Clinical Executive Board, Albuquerque VA Medical Center
  • Member, Leadership Board, Albuquerque VA Medical Center
  • Member, Professional Standards Board, Albuquerque VA Medical Center
  • Member, Peer Review Committee, Albuquerque VA Medical Center
  • Member, Executive Committee, Dept. of Internal Medicine, UNM School of Medicine
  • Member, Search Committee for Chair of Dept. of Pathology, UNM School of Medicine (2008)
  • Member, Search Committee for Chief of Performance Improvement, Albuquerque VA Medical Center (2006)
  • Chair, Search Committee for Chief of Nutrition, Albuquerque VA Medical Center (2007)
  • Member, Search Committee for Associate Director, Albuquerque VA Medical Center (2008)
  • Member, Academic Affiliation Partnership Council, UNM School of Medicine
  • Lead, Cost Resources Work Group, Albuquerque VA Medical Center
  • Member, VA Center of Excellence for Cellular and Molecular Medicine, Albuquerque VA Medical Center
  • Member, Multidisciplinary Advisory Committee, CTSC, UNM School of Medicine (2009)
  • Associate Chief of Staff for Research, Acting, Albuquerque VA Medical Center (2010-)
  • President, Biomedical Research Institute of New Mexico, Albuquerque, NM (2010-)
  • Member (ex officio), Research and Development Committee, Albuquerque VA Medical Center (2010-)

Teaching Experience

01‑07/1992

Chief Medical Resident, Methodist Hospital, Baylor College of Medicine, Houston,TX

1994/95/97

Course Director, Introductory Microbiology and Infectious Diseases Physician Associate Program, Yale University School of Medicine

1996- Course Director, Principles of HIV Disease, Physician Associate Program, Yale University School of Medicine
1995- Lecturer, Yale School of Medicine Faculty Affiliated Hospitals Program
1995/98

Lecturer, Pathophysiology of Infectious Diseases Lecture Series for second year medical students at Yale School of Medicine

1996/98/01 Attending Physician, Atkins Firm, Yale‑New Haven Hospital
1997‑99 Instructor, Dept. of Internal Medicine, Yale University School of Medicine
1997‑

Lecturer, Integrated Clinical Medicine Course for fourth year medical students at Yale School of Medicine

1998

Lecturer, Medical Microbiology Course for second year medical students, Yale School of Medicine

1999 Course Director, Integrated Clinical Medicine, Yale School of Medicine
1999‑ Instructor, Doctor/Patient Encounter Course, Yale School of Medicine
2000- Course Director, Molecular Epidemiology of Bacterial Pathogens (EMD 534b) Dept. Epidemiology and Public Health, Yale School of Medicine
2000 Invited Lecturer, Women's Health Issues, Yale College
2000 Lecturer, Cell Biology Course for first year medical students, Yale School of Medicine
2001 Lecturer, Introduction to Microbial Diseases (EMD 519a), Dept. Epidemiology and Public Health, Yale School of Medicine
2005- Core lecturer, Infectious Diseases Fellowship Program, UNM School of Medicine
2005- Lecturer, Resident Noon Conference Series UNM School of Medicine, Dept. of Internal Medicine
2006- Invited lecturer, Infectious Diseases Block, UNM School of Medicine
2007-

Coach for Science Olympiad, Disease Detectives and Human Anatomy Grades 6-12, Albuquerque Academy

2010- Course Co-Director, Global Emerging Infectious Diseases, UNM School of Medicine
2010- Course Director, Advanced Topics in Global Health, UNM School of Medicine

International Health Experience

06‑08/1994

Attending Physician, Medical Unit, Machame Lutheran Hospital, Machame, Tanzania

1995/1999 Attending Physician, Traveler's Clinic, Yale University Health Services
06/1995

Site Inspector, Nickerie Hospital, Nickerie, Suriname
Working on behalf of the International Health Program, Dept. of Medicine,
Yale University School of Medicine

2001-05 Medical Director, Travel Medicine Program, Yale Health Plan
2005-

Director, Geographic and Global Medicine Program and Center for Global Health, Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico School of Medicine

 

Publications

  1. Conover RJ, Durvasula RV, Roy S, Wang R. Probable Lossof Chlorophyll-derived Pigments During Passage Through the Gut of Zooplankton, and Some of the Consequences. Limnology and Oceanography 1986:31(4), 878‑887
  2. Aksoy S., Beard C.B., Durvasula RV, Hull R., Kang A., O'Neill S.L., Richards F.F. Expression of foreign genes in the symbiotic bacteria in insect vectors. Proceedings of the First International Workshop on Transgenesis of Invertebrates of Medical, Agricultural and Aquacultural Importance, Montpellier, France, 1995.
  3. Durvasula RV, Gumbs A., Panackal A., Kruglov 0., Richards F.F., Beard C.B. Prevention of Chagas disease Transmission: An Approach using Transgenic Symbiotic Bacteria. Mem. Inst. Oswaldo Cruz, Rio de Janeiro, Vol 91, Suppl 1, p.31,1996
  4. Durvasula RV Gumbs A, Panackal A, Kruglov A, Aksoy S,Merrifield RB, Richards F and. Beard CB. Prevention of Insect‑borne  Disease:An Approach Using Transgenic. Symbiotic Bacteria. Proc.Nat. Acad. Sci. USA 1997: 94, 3274‑3278
  5. Beard CB, Durvasula RV and Richards FF. Bacterial Symbiosis in Arthropods and the Control of Disease Transmission. Emerging Infectious Diseases 1998: Vol 4:4, 581‑591
  6. Durvasula RV Gumbs A, Panackal A, Whitharn R, Taneja J, Kang A, Richards'F and Beard CB . Expression of a Functional Antibody Fragment in the Gut of Rhodnius prolixus via the Transgenic Bacterial Symbiont, Rhodococcus rhodnii. Med. Vet. Entomology 1999:13,1‑5
  7. Durvasula RV and Taneja J. Maintenance of triatomine bugs Rhodnius, prolixus and Triatorna dimidiata under laboratory conditions. In Maintenance of Human, Animal and Plant Pathogen Vectors 1999. K. Maramorosch and F. Mahmood eds. 139‑157. Science Publishers Inc. Enfield, NA, New Hampshire 03748 USA pp 328
  8. Durvasula RV Panackal A, Taneja J, Gumbs A, Kruglov 0, Richards F, Beard CB. A Strategy for Spreading Anti‑trypanosomal Genes in Populations of the Chagas disease Vector, Rhodnius prohxus. Annals of The Entomological Society of America 1999: 92(6), 937‑943
  9. Beard CB, Durvasula RV and Richards FF. Bacterial Symbiont Transformation in Chagas Disease Vectors. In Insect Transgenesis. Methods and Applications 2000. AM Handler and AA James eds. 289-303.CRC Press, Boca Raton, Florida 33431 pp 397
  10. Beard CB, Dotson EM, Pennington P, Eichler S,Cordon-Rosales C and Durvasula RV. Bacterial symbiosis and paratransgenic control of vector-borne Chagas disease. Int. J. Parasitology 2001:31, 621-27
  11. Beard CB, Cordon-Rosales C and Durvasula RV. Bacterial Symbionts of the Triatominae and Their Potential Use in Control of Chagas Disease Transmission. Annual Review of Entomology 2002:47, 123-141
  12. Durvasula RV, Sundaram R and Beard CB. A Paratransgenic Strategy for Control of Chagas Disease. Proceedings of  7th International Symposium on Biosafety of Genetically Modified Organisms, Beijing, China 2002
  13. Dotson EM, Pliykatis B,Shinnick TM, Durvasula RV and Beard CB. Transformation of rhodococcus rhodnii, a symbiont    of the Chagas disease vector Rhodnius prolixus, with integrative elements of the L1 mycobacteriophage. Infection, Genetics and Evolution 2003: 74, 1-7
  14. Durvasula RV, Sundaram R and Beard CB. Rhodnius prolixus and Its Symbiont Rhodococcus rhodnii: A Model for Paratransgenic Control of Disease Transmission.  In Insect Symbiosis 2003. K Bourtzis and T Miller eds. pp 85-97. CRC Press, Boca Raton, Florida
  15. Durvasula RV, Sundaram R, Matthews S, Sundaram P and Subba Rao DV. Prospects for Paratransgenic Application to Commercial Mariculture using Genetically Engineered Algae. 2006.  Pp 865-889 Vol 2 in Algal Cultures, Analogues of Blooms and Applications (DV Subba Rao ed ) Science Publishers, Enfield USA
  16. Miller T, Lauzon C, Lampe D, Durvasula R and Matthews S. Paratransgenesis applied to insect-transmitted diseases: The Pierce’s Disease Case. 2006 Chap 15 in Insect Symbiosis 2. Miller T and Bourtzis K, eds. CRC Press, Boca Raton
  17. Durvasula RV, Hurwitz I, Matthews S. Paratransgenic strategies for control of vector-borne diseases: rewards and risks.2007 Entomological Research 37 (Supp 1): A36
  18. Durvasula RV, Hurwitz I, Subhadra B and Matthews S. The spectrum of paratransgenic strategies: from triatomines to shrimp. 2007 Entomological Research 37 (Supp 1): A71
  19. Durvasula RV, Subhadra B, Hurwitz I and Subba Rao DV. Use of Dunaliella species for Paratransgenic Control in Commercial Mariculture. 2008 Dunaliella (Ben-Amotz, Polle and Subba Rao, eds) Science Publishers, Enfield USA
  20. Durvasula RV, Kruglov 0, Taneja J, Dotson E, Sundaram R, Hurwitz I, Richards FF and Beard CB. Identification and genetic transformation of an endosymbiont of the Chagas disease vector, Triatoma infestans. 2008 Experimental Parasitology  119:94-98
  21. Sundaram RK, Matthews S, Kurapati, Hurwitz I, S, Crawford C and Durvasula RV. Expression of a Functional Single Chain Antibody Via the Human Respiratory Commensal, Corynebacterium pseudodiphtheriticum. 2008 European Journal of  Microbiology and Infectious Diseases 27:617-722
  22. Hillesland H, Read A, Subhadra B, Hurwitz I, McKelvey R, Ghosh K, Das P and Durvasula RV.  Identification of Aerobic Gut Bacteria from the Kala Azar Vector, Phlebotomus argentipes: a Platform for Potential Paratransgenic Manipulation of Sandflies.  2008 Am. J. Trop. Med. Hyg. 79(6): 881-886
  23. Subhadra B, Hurwitz I, Fieck A, Subba Rao G, Subba Rao DV and Durvasula RV. Paratransgenic Artemia as a Strategy to Combat Infections of Mariculture. 2009 J Applied Microbiology 108(3): 831-840
  24. Fieck A, Hurwitz I and Durvasula RV. Synergistic Activity of Multiple Amphipathic Peptides to Potential Bacterial Hosts and Trypanosoma cruzi. 2010 Experimental Parasitology 125(4):342-347.
  25. Markiv A, Anani B, Durvasula RV and Kang AS.  Module based antibody engineering: A novel synthetic REDantibody. 2011J Immunol Methods; 364(1-2):40-9.
  26. Matthews S, Vadrevu SHR and Durvasula R. A Predictive Mathematical Model to Evaluate Horizontal Gene Transfer in the Gut of the Chagas Disease Vector, Rhodnius Prolixus. 2011 Parasit Vectors. 4:77
  27. Hurwitz I, Hillesland H, Fieck A, Das P, Durvasula R. The paratransgenic sand fly: A platform for control of Leishmaniasis transmission. 2011Parasit Vectors. 4:82
  28. Ursic-Bedoya R., Buchhop J, , Joy JB, Durvasula RV, and Lowenberger C. Prolixicin: a novel antimicrobial peptide isolated from Rhodnius prolixus with differential activity against bacteria and Trypanosoma cruzi.2011 Insect Molecular Biology. 20: 775-786
  29. Hurwitz I,  Fieck A, Read A, Klein N and Durvasula RV. Paratransgenic Control of Vector-borne Diseases.2011 International Journal of Biological Sciences  31:621-627
  30. Markiv A, Beatson R, Burchell J, Durvasula RVand Kang A . Expression of recombinant multi-coloured fluorescent antibodies in gor -/ trxB – E. coli cytoplasm. 2011BMC Biotechnology 11:117
  31. Fieck A, Hurwitz I, Jose C and Durvasula RV. Use of antimicrobial peptides for paratransgenic control of infectious diseases.2012Current Drug Targets Aug;13(9):1173-80.
  32. Hurwitz I, Jose C and Durvasula RV. Paratransgenic Control of Trypanosoma cruzi Transmission by Triatomine Bugs. 2012Psyche: Special Issue on True Bugs (Heteroptera): Chemical Ecology of Invasive and Emerging Pest SpeciesVolume 2012 (2012), Article ID 178930, 10 pages doi:10.1155/2012/178930
  33.  Durvasula RV and Lin H. Probiotics: Evolving Therapeutics. 2012 CRC Press-Science Publishers invited book editorship
  34. Klein N, Hurwitz I and Durvasula RV.Globalization of Chagas Disease: A Growing Concern in Nonendemic Countries. 2012 Epidemiology Research International  Article ID# 136793 doi: 10.1155/ 2012/ 136793
  35. Mao J and Durvasula RV.Lung cancer chemoprevention: current status and future directions.2012 Current Respiratory Care Reports  1: 9-20 
  36. Durvasula RV and Dotson E. Maintenance of triatomine bugs Rhodnius, prolixus and Triatorna dimidiata under laboratory conditions. In Maintenance of Human, Animal and Plant Pathogen Vectors 2012. K. Maramorosch and F. Mahmood eds.  Science Publishers Inc.  in press
  37. Bourtzis K, Crook S, Daffonchio D, Durvasula R, Hanboonsong Y, Infante F, Lacava P, Miller T and Vega F. International Entomology. 2012 American Entomologist 58:4; 234-45
  38. Durvasula RVand Vadrevu SHR (editors).  Dynamic Models of Infectious Diseases. Volume 1: Vector-Borne Diseases 2013, XII, 292 p. Springer, New York
  39. Read A, Hurwitz I and Durvasula RV. Leishmaniasis: An Update on a Neglected Tropical Disease. In DYNAMIC MODELS OF INFECTIOUS DISEASES2013, 95-138, DOI: 10.1007/978-1-4614-3961-5_4. Springer, New York
  40. Klein N, Hurwitz I and Durvasula RV.  Chagas disease: Global Epidemiology and Evolving Methods of Control. In DYNAMIC MODELS OF INFECTIOUS DISEASES2013, 139-167, DOI: 10.1007/978-1-4614-3961-5_5, Springer, New York
  41. Arora A, Durvasula RV and Miller T. Use of Taqman Minor Groove Binder Probes to Distinguish Between Two Pathogenic Strains of Xylella fastidiosa. 2014 International Journal of Biotech Trends and Technology in press
  42. Durvasula RV, Hurwitz I and Dotson E. Paratransgenic manipulation of Triatomine Bugs. J Visualized Experiments 2014 invited paper
  43. Jose C, Klein N, Wyss S, Fieck A, Hurwitz I and Durvasula RV.  Recombinant Arthrobacter B 1-3 glucanase as a potential effector molecule for paratransgenic control of Chagas disease. 2013 Parasites and Vectors 6:65
  44. Durvasula RV. Taking a bite out of mosquitoes: A novel drug class for blocking transmission of malaria (Editorial). 2013 Journal of Infectious Diseases  209:2  pp177-179
  45. Durvasula RV, Vadrevu SH Rao and DV Subba Rao. Microalgal Biotechnology: Today’s (Green) Gold Rush. In Biotechnical Applications of Microalgae 2013, 200- 225, Frances and Taylor, Publishers
  46. Satoskar A and Durvasula RV (editors). Pathogenesis of Leishmaniasis: New Developments in Research2014, 91 pages,  Springer, New York
  47. Forshaw A and Durvasula RV. A Novel Microencapsulation Strategy to Preserve Biopesticides in Arid Regions of the World. 2014 PLoS One  under revision
  48. Arora A, Forshaw A, Miller T, Kang A and Durvasula RV. A Novel Microencapsulation Strategy for Field Application of Paratransgenic Control. 2014 BMC Biology submitted
  49. Durvasula RV, Hurwitz I, Fieck A and Subba Rao DV. Scenedesmus species Novo: A Novel Extremophile Alga from Jemez Springs, New Mexico. 2014 Algal Research  submitted
  50. Hurwitz I, Jose C, Klein N, Forshaw A and Durvasula RV. Paratransgenic Strategies for Targeting Vectorial Transmission of Chagas disease. In Insect Transgenesis 2014, Benedict M, ed. CABI  in press
  51. Hurwitz I, Forshaw A, Ramalho-Ortigao M, Satoskar A and Durvasula RV. Paratransgenic Control of Leishmaniasis: New Developments. In Pathogenesis of Leishmaniasis: New Developments in Research2014, pp 25-45,  Springer, New York
  52. Maleki-Ravasan N, Oshagi M, Afshar D, Arandian M, Hajikhani S, Akhavan A, Yakhchali B, Shirazi M, Jafari R, Durvasula RV and Rassi Y. Aerobic bacterial flora of biotic and abiotic components of a hyperendemic Zoonotic Cutaneous Leishmaniasis (ZCL) focus. 2014 Parasites and Vectors  in press
  53. Durvasula RV and Durvasula SV. Marine Extremophilic Algae: From Biology to Biotechnology. 2014 Invited Book Editorship, CRC Press
  54. Idris A, Miller T, Durvasula R and Federoff N. Bridging the knowledge gaps for development of red palm weevil IPM.In Management of  Red Palm Weevil 2015, Wakas W editor, CABI in press
  55. Abdellaoui , Jouani A, Forshaw A, Cherif A and Durvasula RV. A Microencapsulated Fungus for Control of L. migratoria in Tunisia. 2014 J Applied Microbiology submitted
  56. Wael M, Zhouia E, Hurwitz I and Durvasula RV. A Survey of Aerobic Microflora of P. papatasi from Endemic Regions for Zoonotic Cutaneous Leishmaniasis in Tunisia.2014 Parasites and Vectors submitted
  57. Ogaugwe C, Cheng Q, Hurwitz I and Durvasula RV. Endogenous promoters of Lactococcus lactis: Optimized conditions for heterologous protein expression. 2014 BMC Microbiology submitted
  58. Markiv A, Durvasula RV and Kang AS. Fluorescent Fusion Polypeptides and Methods of Use. 2014 US Patent # 8,877,898
  59. Kunamneni A and Durvasula RV. Streptokinase- A Drug for Thrombolytic Therapy: A Patent Review. 2015 Recent Patents on Cardiovascular Drug Discovery  accepted for publication

Selected Peer Reviewed Abstracts and Conference Proceedings

  1. Durvasula RV, Aksoy S., Beard C.B., Richards F.F. Expression of Cecropin A, an anti­trypanosomal peptide, in endosymbiotic bacteria of Rhodnius prolixus. Mem. Inst. Oswaldo Cruz, Rio de Janeiro, Vol. 90, Suppl L p.25,1995.
  2. Durvasula RV, Aksoy S., Beard C.B., Richards F.F. Expression of Cecropin A, an anti‑ trypanosomal peptide, in endosymbiotic bacteria of Rhodnius prolixus. Proceedings of the Molecular Parasitology Meeting, Woods Hole, MA, p.88,1995.
  3. Durvasula RV, Aksoy S., Beard C.B., Richards F.F. Expression of Cecropin A, an anti- trypanosomal peptide, in the Chagas disease vector, Rhodnius prolixus. Abstract #377, IDSA 33rd Annual Meeting, San Francisco, CA, 1995.
  4. Durvasula RV, Aksoy S., Beard C.B., Richards F.F. Expression of Cecropin A, an anti­- trypanosomal peptide, in endosymbiotic bacteria of Rhodnius prolixus. Am. J. Of Trop. Med and Hygiene (suppl.) 53:2, Abstract #345, 1995
  5. Lee H., Goodwin M., Crawford C. and Durvasula RV. Application of the Vector Symbiont Method to the Chagas Disease Vector, Triatoma dimidiata. Proceedings of 24th Annual Meeting on Basic Research in Chagas disease, Caxambu, Brazil 1997
  6. Durvasula RV, Richards F.F., Aksoy S and Beard C.B. The Vector Symbiont Method: A Novel Approach to the Control of Chagas disease Transmission. Proceedings of the Second International Workshop on Transgenesis of Invertebrates of Medical, Agricultural and Aquacultural Importance, Asilomar, California 1997
  7. Dotson EM, Rosenberg 0, Phykatis B, Lyman DF, Shinnick TM, Durvasula RV,Richards FF and Beard CB. Transformation of Bacterial Symbionts in Chagas Disease Vectors by Integration with Ll Integrase. Am. J. Of Trop. Med and Hygiene (suppl.) 59:3, Abstract # 193,1998
  8. Dotson EM, Durvasula RV and Beard CB. Use of Bacterial Symbionts in the Control of Chagas Disease. Proceedings of the Third International Workshop on Transgenesis of Invertebrates of Medical, Agricultural and Aquacultural Importance, Crete, Greece 1999.
  9. Dotson EM, Plikaytis B, Shinnick TM, Durvasula RV, and Beard CB. Use of mycobacteriophage‑derived integrative elements in the transformation of Rhodococcus rhodnii, a symbiont of the Chagas disease vector, Rhodnius prolixus. Proceedings of 47th Annual Meeting of The Entomological Society of America, Atlanta, Georgia 1999
  10. Durvasula RV, Richards FF and Beard CB. Paratransgenesis of the Reduviid Vectors of Chagas Disease. Proceedings of 47th Annual Meeting of the Entomological Society of America, Atlanta, Georgia 1999.
  11. Durvasula RV, Richards FF, Beard CB and Cordon-Rosales C. Paratransgenesis of the Reduviid Vectors of Chagas Disease. Proceedings of 24th International Congress of Entomology, Iguassu Falls, Brazil 2001
  12. Durvasula RV, Sundaram R and Beard CB. Toward Paratransgenic Control of Chagas Disease. Proceedings of 29th Annual Meeting on Basic Research in Chagas disease, Caxambu, Brazil 2002
  13. Matthews S, Beard CB, Sundaram R and Durvasula RV. A Mathematical Model to Predict Horizontal Gene Transfer During Paratransgenic Control of Chagas Disease. Proceedings of Fourth International Workshop on Transgenesis of Invertebrate Organisms, Asilomar, California 2003
  14. Durvasula RV, Sundaram R, Dotson E and Beard CB. Update on Paratransgenic Approaches to Reduviid Vectors of Chagas Disease, Proceedings of Fourth International Workshop on Transgenesis of Invertebrate Organisms, Asilomar, California 2003
  15. Kurapati S, Sundaram R and Durvasula RV. Expression of a Functional Single Chain Antibody in Corynebacterium Pseudodiphtheriticum. Abstract #776. 41st Annual Meeting of IDSA, San Diego, CA 2003
  16. Durvasula RV, Sundaram R, Matthews S and Beard CB. Proceedings of  51st Annual Meeting of The Entomological Society of America, Cincinnati, OH 2003
  17. Matthews S, Sundaram R and Durvasula RV.  A Mathematical Model to Predict Horizontal Gene Transfer During Paratransgenic Control of Chagas Disease. 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA 2003, Abstract # 1613
  18. Sundaram R, Matthews S and Durvasula R.  Transmission Blocking Antibodies:Effect of a Monoclonal Antibody on  Transmission of Trypanosoma cruzi. 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA 2003, Abstract # 2047
  19. Smith D, Murphy G and Durvasula R. Impact of an Electronic Registry on Outcome of a Population of Patients with Diabetes Mellitus.  Annual Meeting of The Society of General Internal Medicine, Chicago, IL 2004
  20. C. Romero, Pamela Pennington, Celia Cordón-Rosales, Ellen B. Dotson, C.B. Beard, Ravi Durvasula.
  21. Potential of the house fly, Musca domestica, as a vector of transgenic symbionts of Rhodnius prolixus, a Chagas disease vector. Abstract # Y-049, Annual Meeting of The American Society of Microbiology, New Orleans, LA 2004
  22. Jennifer Anderson, Roberto Archila, Cynthia Ralda, Celia Cordón-Rosales, Ravi Durvasula, Charles B. Beard, Ellen M. Dotson, Pamela M. Pennington. Symbiotic potential of the bacterial flora of domestic triatomine vectors of Central America. Annual Meeting of The American Society of Microbiology, New Orleans, LA 2004
  23. Matthews S, Sundaram R and Durvasula RV.  A Risk Assessment Framework for Paratransgenic Control of Chagas Disease. “Biotech Bugs Conference” of The Pew Initiative, Washington DC, 2004
  24. Romero C., Pennington P., Cordón-Rosales C., Dotson EB, Beard CB, Durvasula RV. Potential of the house fly, Musca domestica, as a vector of transgenic symbionts of Rhodnius prolixus, a Chagas disease vector. “Biotech Bugs Conference”of The Pew Initiative, Washington DC, 2004
  25. Hurwitz I, Matthews S and Durvasula RV. Paratransgenic Strategies for control of Kala Azar. 55th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA 2006
  26. Hillesland H, Hurwitz I, Subhadra B, Matthews S, Read A, Das P, Ghosh K and Durvasula RV. Aerobic Gut Bacteria of Phlebotomus argentipes. 56th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA 2007
  27. Fieck A, Hurwitz I, Durvasula RV. Activity of AMP’s against Trypanosoma cruzi. 56th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA 2007
  28. Read A, Hurwitz I and Durvasula RV. Paratransgenic Strategies for Control of Indian Visceral Leishmaniasis. Young Investigator Competition. 56th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA 2007
  29. Durvasula RV, Hurwitz I, Subhadra B and Matthews S. Paratransgenic Strategies for Control of Infectious Diseases.  95th Annual Indian National Science Congress, Visakhapatnam, India 2008
  30. Subba Rao DV and Durvasula RV. Marine Biotechnology and Prospects for Indian Development. 95th Annual Indian National Science Congress, Visakhapatnam, India 2008
  31. Fieck A, Hurwitz I and Durvasula RV. Evaluation of Cytotoxic Activity of Multiple Amphipathic Molecules Against Trypanosoma cruzi. 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene, New Orleans, LA 2008
  32. Subhadra B, Hurwitz I, Fieck A and Durvasula RV.  Development of Paratransgenic Shrimp (Litopenaeus vannamei): a potential Strategy for Control of Infectious Diseases of Commercial Mariculture. World Aquaculture Society 2009, Seattle, WA
  33. Subadhra B, Hurwitz I, Fieck A and Durvasula RV. Vibriocidal Activities of Anti-Microbial Peptides. World Aquaculture Society 2009. Seattle, WA
  34. Hurwitz I, Fieck A and Durvasula RV. Development of Paratransgenic Approaches to Human Clostridium difficile Infections. BIT International Conference 2009, Beijing, China
  35. Durvasula RV and Hurwitz I. Paratransgenic Approaches to Control of Infectious Disease Transmission. BIT International Conference 2009, Beijing, China
  36. Hillesland H *, Hurwitz I, Kumar V, Das P and Durvasula RV. Paratransgenic Strategies to Control Visceral Leishmaniasis. 58th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC 2009

Awarded Honorable Mention In Young Investigator Competition

  1. Hillesland H, Hurwitz I, Das P, Matthews S and Durvasula RV. Engineered nano-particles for delivery of molecules to Phlebotomus argentipes. 58th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC 2009
  2. Fieck A, Hurwitz I and Durvasula RV. Expression of cytotoxic antimicrobial peptides with activity against Trypanosoma cruzi. 58th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC 2009
  3. Subhadra B, Hurwitz I, Fieck A and Durvasula RV. Bio-amplification of Peptides through a Paratransgenic Approach in Commercial Shrimp Mariculture. World Aquaculture Society 2010, San Diego, CA
  4. Subhadra B, Vadrevu SHR, Subba Rao DV and Durvasula RV. A Blueprint for Algal Biofuel Development in New Mexico. Southwest Biofuels Symposium 2010, Albuquerque, NM
  5. Durvasula RV, Fieck A and Hurwitz I. First and Second Generation Paratransgenics for Control of Infectious Diseases. Annual Meeting of The Mexican Immunoparasitology Society 2010, Mexico City, Mexico 
  6. Durvasula, RV., Paratransgenic approaches to arthropod-borne diseases - Act 1, in 1st BioDesert Consortium on Bacterial Symbiosis2011: Tunis, Tunisia.
  7. Forshaw, A. and Durvasula, R., Paratransgenic approaches to arthropod-borne disease - Act 2 (Risk assessment and mitigation), in 1st BioDesert Consortium on Bacterial Symbiosis 2011: Tunis, Tunisia.
  8. Forshaw A, Miller T and Durvasula R. Microencapsulation of Agro-Pest Biocontrol Agents to Enhance Global Food Security. Abstract # 582. 61st Annual Meeting of The American Society of Tropical Medicine and Hygiene. Atlanta Ga 2012
  9. Hurwitz I, Fieck A, Kang A, Ramalho-Ortigao M and Durvasula R. Use of a novel fluorscent-labeled antibody for paratransgenic control of leishmanisis. Abstract #1017. 62nd Annual Meeting of The American Society of Tropical Medicine and Hygiene. Washington DC 2013
  10. Forshaw A, Hurwitz I, Ramalho-Ortigao M, Weng J, Heerman M and Durvasula R. Material Science and Paratransgenesis: An Updated Approach to Control Transmission of Leishmaniasis by Sand Flies. Abstract # 576. 62nd Annual Meeting of The American Society of Tropical Medicine and Hygiene. Washington DC 2013

 

Autoimmune Journal Flyer